Related Experiment Video

Updated: Mar 8, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.9K

Atypical Pneumonia: Updates on Legionella, Chlamydophila, and Mycoplasma Pneumonia

Lokesh Sharma1, Ashley Losier2, Thomas Tolbert3

  • 1Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, 300 Cedar Street, TAC S440, New Haven, CT 06510, USA.

Clinics in Chest Medicine
|February 5, 2017
PubMed

Insights

Atypical community-acquired pneumonia (CAP) presents diagnostic challenges, often leading to undertreatment. This review covers recent advancements in evaluating and managing atypical CAP, including Legionella, Chlamydophila, and Mycoplasma infections.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Community-acquired pneumonia (CAP) is a significant cause of hospitalization and mortality.
  • Atypical CAP, caused by pathogens like Legionella, Chlamydophila, and Mycoplasma, poses diagnostic difficulties.
  • Underdiagnosis and undertreatment of atypical CAP are prevalent issues.

Purpose of the Study:

  • To review recent advancements in the diagnosis and treatment of atypical CAP.
  • To discuss current challenges, controversies, and clinical management strategies for atypical CAP.
  • To highlight the importance of accurate identification and management of atypical pathogens.

Main Methods:

  • Literature review of recent studies on atypical CAP diagnosis and treatment.
  • Analysis of current guidelines and expert opinions.
  • Discussion of diagnostic modalities and therapeutic options for atypical CAP.

Main Results:

  • Diagnostic challenges persist for atypical CAP, impacting timely and appropriate treatment.
  • Emerging diagnostic tools and therapeutic strategies offer potential improvements.
  • Understanding pathogen-specific characteristics is crucial for effective management.

Conclusions:

  • Accurate and timely diagnosis of atypical CAP is essential to reduce morbidity and mortality.
  • Continued research and clinical vigilance are necessary to address the complexities of atypical CAP.
  • Optimized treatment strategies based on pathogen identification are critical for patient outcomes.
Keywords:
ChlamydophilaCommunity-acquired pneumonia (CAP)LegionellaLegionnaires’ diseaseMycoplasmaPontiac feverWalking pneumonia

More Related Videos

Use of Galleria mellonella as a Model Organism to Study Legionella pneumophila Infection12:30

Use of Galleria mellonella as a Model Organism to Study Legionella pneumophila Infection

Published on: November 22, 2013

41.6K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.7K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.8K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
979
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
678